Altogether, our findings demonstrate that GPR92, a GPCR expressed in IMs and highly modulated by a HFD, controls the chronic inflammatory pathways that drive the pathogenesis of obesity-related diabetes. Here, LPAR5 is linked to diabetes mellitus.